Round-Window Microcatheter-administered microdose gentamicin: Results from treatment of tinnitus associated with Meniere's disease

M. J. DeCicco, M. E. Hoffer, R. D. Kopke, D. Wester, K. A. Allen, K. Gottshall, M. J. O'Leary

Research output: Contribution to journalArticle

37 Scopus citations

Abstract

In this study, we review the results of Meniere's disease treatment using microdose gentamicin delivered directly to the round window using the Round Window Microcatheter (IntraEar, Inc., Denver, CO). A total of 18 patients were studied, with follow-up ranging from 6 to 18 months. In 15 of 18 patients (83%), tinnitus was improved significantly thruoghout the follow- up period. Vertigo was eliminated in all patients, and pressure was relieved in 17 of 18 (94%). These preliminary data suggest that Round Window Microcatheter-delivered gentamicin is a safe and effective treatment for the reduction of tinnitus, vertigo, and pressure associated with Meniere's disease.

Original languageEnglish (US)
Pages (from-to)141-143
Number of pages3
JournalInternational Tinnitus Journal
Volume4
Issue number2
StatePublished - Dec 1 1998
Externally publishedYes

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Sensory Systems
  • Speech and Hearing

Fingerprint Dive into the research topics of 'Round-Window Microcatheter-administered microdose gentamicin: Results from treatment of tinnitus associated with Meniere's disease'. Together they form a unique fingerprint.

  • Cite this